All News

A study found that taking as few as 4000 steps per day on just 1 to 2 days each week significantly reduces mortality in women aged 62 years and older.

Natasha Spencer, MD, discusses how updated prenatal guidelines, advanced screening, and proactive patient education are helping older women achieve healthy, uncomplicated pregnancies.

A new study reveals that nearly 20% of urinary tract infections in Southern California may stem from E. coli strains found in contaminated meat.

A new study finds that while antenatal corticosteroids remain safe for very preterm infants, their use in later gestations may increase long-term infection risk.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Explore innovative menopause management strategies for BRCA carriers, including testosterone therapy, to alleviate symptoms and enhance quality of life.

Research at The Menopause Society 2025 meeting highlighted safety, education, and individualized care in menopause management.

A new study finds that 1-mg/day dienogest offers comparable pain reduction to a 2-mg/day dose for endometriosis while maintaining a favorable safety profile.

Declining national screening rates highlight the need for increased investment, education, and innovative approaches to expand access.

Study finds women on hormone therapy lost more weight with tirzepatide, though researchers stress association—not causation—needs confirmation.

Fertility expert Lucky Sekhon, MD, and Olympic gold medalist Tara Lipinski discuss the psychological challenges of infertility.

New data suggest hormone therapy may increase autoimmune disease risk in postmenopausal women, highlighting the need for clinical vigilance.

Zoliflodacin study investigator Sarah McLeod, PhD, highlights data presented at IDWeek 2025 in a Q&A.

A large analysis found that stillbirths occur more often than CDC estimates, and many cases lack identifiable clinical risk factors.

Experts highlight future research in personalized menopause care, exploring hormone safety, the microbiome, cognition, and metabolic health.

Experts compare hormone and nonhormonal options for menopause, emphasizing tailored care, persistent symptom relief, and safe use of local estrogen.

Experts discuss how neurokinin receptor antagonists offer rapid, durable, and nonhormonal relief for vasomotor symptoms, reshaping menopause care.

Experts discuss neurokinin receptor drugs, CBT, and lifestyle tools for managing vasomotor symptoms, emphasizing innovation and evidence-based care.

Experts discuss contraindications to hormone therapy and evolving care for women with early or surgical menopause, emphasizing individualized treatment.

Experts review updated VMS treatment guidelines and stress shared decision-making to personalize hormone and nonhormone therapy options.

Experts emphasize normalizing menopause discussions early to reduce stigma and improve communication in both clinical and workplace settings.

Experts discuss how culture, stigma, and inequities shape menopause care and leave many women without adequate symptom management.

Experts highlight education, equity, and access gaps in vasomotor symptom care, calling for stronger clinician training and awareness.

Experts discuss updates in the management of vasomotor symtpoms in menopause, including unmet needs, quality of life impacts, and new therapies.

Nearly 30% of long COVID patients show signs of postural orthostatic tachycardia syndrome, a condition tied to worsened fatigue and recovery.

Erin Donnelly Michos, MD, discusses optimizing cardiovascular disease prevention in women through earlier risk assessment and tailored management.

Earlier menopause accelerates memory decline in women with APOE ε4 or inflammation, highlighting sex-specific Alzheimer disease risk factors.

Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.